Competitive, selective, voltage-dependent open-channel Ca2+ permeable GluA2 (GluR2)-lacking AMPA receptor blocker (IC50 values are 2.6 and 1102 µM at GluA2-lacking and GluA2-containing AMPARs respectively).
IEM-1460 can be utilized as an indicator of the distribution of AMPA receptor subtypes among populations of brain cells.
IEM-1460 can also be used to selectively target GABAergic interneurons, as several subpopulations of these neurons express a significant proportion of GluA2-lacking Ca2+-permeable AMPARs.
Blocks synaptic excitation of fast-spiking interneurons and blocks NMDAR-mediated currents.
Also shows anticonvulsant properties.
Solubility & Handling
Storage instructions
Room temperature (desiccate)
Solubility overview
Soluble in water (100mM) or DMSO (100mM)
Important
This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use.
The open channel blocking drug, IEM-1460, reveals functionally distinct alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors in rat brain neurons.